100 related articles for article (PubMed ID: 10595646)
1. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
Ngo TH; Declerck PJ
Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
Ngo TH; Verheyen S; Knockaert I; Declerck PJ
Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
[TBL] [Abstract][Full Text] [Related]
3. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.
Leng HM; Brouwers E; Knockaert I; Declerck PJ
Thromb Haemost; 2000 Dec; 84(6):1082-6. PubMed ID: 11154117
[TBL] [Abstract][Full Text] [Related]
4. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
Declerck PJ; Verstreken M; Collen D
Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation.
Ngo TH; Verheyen S; Knockaert I; Declerck PJ
J Pharm Belg; 1997; 52(4):165-6. PubMed ID: 9316343
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
[TBL] [Abstract][Full Text] [Related]
7. Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1).
Declerck PJ; Moreau H; Jespersen J; Gram J; Kluft C
Thromb Haemost; 1993 Nov; 70(5):858-63. PubMed ID: 8128446
[TBL] [Abstract][Full Text] [Related]
8. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
9. [Plasminogen activator-inhibitor 1: biochemical, structural and functional studies].
Declerck P
Verh K Acad Geneeskd Belg; 1993; 55(5):457-73. PubMed ID: 8128782
[TBL] [Abstract][Full Text] [Related]
10. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.
Friederich PW; Levi M; Biemond BJ; Charlton P; Templeton D; van Zonneveld AJ; Bevan P; Pannekoek H; ten Cate JW
Circulation; 1997 Aug; 96(3):916-21. PubMed ID: 9264501
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and application of monoclonal antibodies against PAI-1.
Ding H; Wu X; Zhou X; Zhu Y; Song H
Chin J Biotechnol; 1994; 10(2):121-8. PubMed ID: 7803688
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin.
Brogren H; Sihlbom C; Wallmark K; Lönn M; Deinum J; Karlsson L; Jern S
Thromb Res; 2008; 122(2):271-81. PubMed ID: 18508114
[TBL] [Abstract][Full Text] [Related]
13. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid.
Rao JS; Chen M; Festoff BW
J Neurosci Res; 1993 Feb; 34(3):340-5. PubMed ID: 8455210
[TBL] [Abstract][Full Text] [Related]
15. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms.
Debrock S; Declerck PJ
Biochim Biophys Acta; 1997 Feb; 1337(2):257-66. PubMed ID: 9048903
[TBL] [Abstract][Full Text] [Related]
17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1.
Bijnens AP; Ngo TH; Gils A; Dewaele J; Knockaert I; Stassen JM; Declerck PJ
Thromb Haemost; 2001 May; 85(5):866-74. PubMed ID: 11372681
[TBL] [Abstract][Full Text] [Related]
19. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
20. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
